Rituximab’s Role in Lupus Set for Further Randomized Trials

Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in which rituximab is used in the first-line treatment of SLE.
Medscape Medical News

source https://www.medscape.com/viewarticle/rituximabs-role-systemic-lupus-erythematosus-set-further-2025a1000b60?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost